Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Name: A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults — clinical trial record (NCT07034781)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated June 24, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Summary

To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Trial Details

NCT Number	NCT07034781
Lead Sponsor	AJU Pharm Co., Ltd.
Conditions	Type2 Diabetes Mellitus
Enrollment	50 participants
Start Date	2025-08
Primary Completion	2025-11 (estimated)
Study Completion	2025-11 (estimated)
Updated on ClinicalTrials.gov	2025-06-24